Corporate Finance

With €10M in new funding, Berlin-based Cellbricks is moving its biofabricated human tissues from lab to preclinical trials, promising a new era for patients.

Alongside Google and Nvidia, QuickFi's AI lending platform is revolutionizing the $1.3T equipment finance market. Here's how it's creating a new industry model.

Following a 40-year career shaping biotech finance, Jessica Chutter's move to PTC's board signals major strategic ambitions for the rare disease firm.

With a massive new launch, Suave is directly challenging luxury brands by offering high-performance 'dupes' at a fraction of the cost. Is this the new normal?

A battle for control erupts at Apimeds Pharmaceuticals as majority shareholders oust the board over a disputed 1000 bitcoin asset from a recent merger.

With $138M in total funding, Endogenex is advancing a novel device that aims to redefine type 2 diabetes treatment by healing the gut, not just managing symptoms.

With a new $200M funding round, legal AI leader Harvey is now valued at $11 billion, signaling a fundamental shift in how law is practiced worldwide.

Biolojic Design's adaptive AI drug for asthma and eczema hits a key milestone with Teva, heralding a new era for personalized autoimmune treatment.

With a new $20M in funding, Charlotte-based Lucid Bots is expanding its fleet of AI-powered drones and robots, transforming blue-collar work from the ground up.

A new tool lets teachers replay a student's entire writing process to ensure originality in the AI era, sparking a debate over integrity and privacy.

The firm's top spot in the Dallas Business Journal ranking highlights its regional dominance, but what does it mean for local investors and the DFW economy?

GSD seeks dual US-based accreditations, a strategic move to bolster its global standing and elevate student value in a competitive academic landscape.

The settlement over foundational antenna tech reveals a high-stakes legal battleground hidden inside the booming Internet of Things and connected devices.

The 2026 QS University Rankings are out, showing Asia, the Middle East, and Latin America challenging the long-held dominance of US and UK institutions.

Swedish biotech VERIGRAFT begins a pivotal trial for a personalized, lab-grown vein, offering hope for a true cure for millions with chronic venous insufficiency.

LGT Wealth Management UK partners with AI platform Addepar, signaling a major tech upgrade to personalize service for the modern, complex investor.

Amid a full-year revenue drop, the EdTech firm unveils a new AI product, banking on innovation and a new business model to chart a path to profitability.

With two renowned physician leaders, Pediatrix signals a major push into AI-driven innovation and health equity for maternal and child medicine.

Rithm Capital declared its 52nd straight dividend. Is its high yield and analyst praise enough to overcome recent stock woes and market skepticism?

In a decisive move to strengthen its balance sheet, the essential minerals firm is using cash on hand to retire debt early, boosting investor confidence.